MedTrace Logo

Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

NCT02213562 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-08-17

No results posted yet for this study

Summary

The aim of this study is to investigate the efficacy and dose-dependency of chrysanthemum flower oil in suppressing serum uric acid.

Conditions

  • Hyperuricemia

Interventions

DIETARY_SUPPLEMENT

200 mg of chrysanthemum flower oil

DIETARY_SUPPLEMENT

300 mg of chrysanthemum flower oil

DIETARY_SUPPLEMENT

400 mg of chrysanthemum flower oil

Sponsors & Collaborators

  • Kaneka Corporation

    collaborator INDUSTRY

  • Hiroshima University

    lead OTHER

Principal Investigators

  • Fumiko Higashikawa, PhD · Hiroshima University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213562 on ClinicalTrials.gov